Compare · AZTA vs LRCX
AZTA vs LRCX
Side-by-side comparison of Azenta Inc. (AZTA) and Lam Research Corporation (LRCX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AZTA and LRCX operate in Industrial Machinery/Components (Technology), so they compete in similar markets.
- LRCX is the larger of the two at $358.31B, about 418.9x AZTA ($855.4M).
- Over the past year, AZTA is down 30.4% and LRCX is up 290.7% - LRCX leads by 321.1 points.
- Both names hit the wire about 6 times in the past 4 weeks.
- LRCX has more recent analyst coverage (25 ratings vs 15 for AZTA).
- Company
- Azenta Inc.
- Lam Research Corporation
- Price
- $19.28+3.88%
- $292.27+2.01%
- Market cap
- $855.4M
- $358.31B
- 1M return
- -14.96%
- +13.09%
- 1Y return
- -30.40%
- +290.72%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1984
- News (4w)
- 6
- 6
- Recent ratings
- 15
- 25
Azenta Inc.
Azenta, Inc. provides manufacturing automation solutions for the semiconductor industry, and life science sample-based services and solutions for the life sciences market worldwide. The company operates in two segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated ultra-cold storage systems and consumables, including racks, tubes, caps, plates, and foils; instruments, such as labeling, bar coding, capping, de-capping, auditing, sealing, peeling, piercing tubes, and plates. The Life Sciences Services segment offers genomic services and sample repository solutions, including on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting; and informatics provides sample intelligence software solutions, which support laboratory workflow scheduling for life science tools and instrument work cells, sample, inventory and logistics, environmental and temperature monitoring, clinical trial and consent management, and planning, data management, virtualization and visualization of sample collections. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
Lam Research Corporation
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.
Latest AZTA
- SEC Form 10-Q filed by Azenta Inc.
- Azenta Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029
- President Multiomics Martin William E. Iii was granted 17,790 units of Common (SEC Form 4)
- Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast
- SEC Form 3 filed by new insider Martin William E. Iii
- Azenta Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution
- Azenta Inc. filed SEC Form 8-K: Other Events
- Amendment: SEC Form SCHEDULE 13G/A filed by Azenta Inc.
Latest LRCX
- Seaport Research Partners initiated coverage on Lam Research with a new price target
- Senior Vice President Fernandes Neil J sold $4,635,894 worth of shares (18,170 units at $255.14) as part of a pre-agreed trading plan, decreasing direct ownership by 22% to 66,129 units (SEC Form 4)
- Chief Legal Officer Harter Ava sold $1,554,547 worth of shares (6,010 units at $258.66) and exercised 6,010 shares at a strike of $77.04 (SEC Form 4)
- SEC Form 10-Q filed by Lam Research Corporation
- Lam Research Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Lam Research Corporation Reports Financial Results for the Quarter Ended March 29, 2026
- Lam Research downgraded by Erste Group
- Lam Research downgraded by Erste Group
- Lam Research Corporation Announces March Quarter Financial Conference Call
- Amendment: SEC Form SCHEDULE 13G/A filed by Lam Research Corporation